Objective: To determine whether tolerance and enhancement of innate immune function can be induced by the Gram-positive cell wall component peptidoglycan. Design: Controlled, in vivo laboratory study. Subjects: Male mice, 8 -12 wks (C57BL6/J; C3H/HeJ; B6.129-Tlr2 tm1kir /J).
ndotoxin (lipopolysaccharide, LPS) is a molecule found in the cell wall of Gram-negative bacteria. Injection of endotoxin initiates a dramatic proinflammatory response that, if untreated, can result in profound hemodynamic derangements and may even progress to shock and death. Interestingly, animals that survive a sublethal exposure to endotoxin are resistant to subsequent challenges with normally lethal doses of LPS during the first few days following the initial exposure (1) . Further, exposure to endotoxin may confer resistance to inflammation and injury induced by other challenges including myocardial infarction (2, 3) , neural ischemia (4, 5) , and gastric insults (6, 7) . Although the cytokine profile in LPS-tolerant animals is similar to that seen in septic patients, innate immune function in the LPS-tolerant state actually seems improved in that bacterial clearance is enhanced and mortality is suppressed after a Gram-negative bacterial challenge (8) . We have previously shown that LPS pretreatment not only diminishes the inflammatory response but also seems to enhance the effectiveness of the innate immune system to clear both Gram-negative and Grampositive bacterial challenges (9 -11) .
Although Gram-negative bacteria have historically been a major cause of sepsis in clinical patients, the incidence of Gram-positive bacterial sepsis has risen significantly over the last decade. During the same time, investigators have ad-vanced our understanding of the process employed by innate immune cells to detect, and react to, a myriad of microbial organisms. It is now known that innate detection of offending microorganisms is dependent upon recognition of a small number of molecules that are common to broad classifications of microorganisms. Toll-like receptors (TLRs) and other receptors mediate the inflammatory effects and innate immune function in response to invading microorganisms. For example, Gram-negative bacteria are detected, at least in part, by the presence of LPS which elicits an innate immune response through TLR4 (12, 13) . In light of the recent findings that different receptors are activated by Gram-positive bacterial molecules compared with activation by Gram-negative bacterial molecules, we were curious to extend our recent findings on bacterial clearance after tolerance induction. During an infection, it is likely that multiple receptors are activated by different bacterial molecules. How the host responds to different bacterial ligands and how prior exposures may influence responses to infection are basic questions that may ultimately provide insight into the pathogenesis of sepsis. We were interested in determining if tolerance could be induced by molecules from the cell wall of Gram-positive bacteria and, if so, whether this tolerant state would also be associated with an enhanced innate immune function after a live bacterial challenge. The aim of this study was to determine whether peptidoglycan (PGN) could induce tolerance to a subsequent Gram-positive bacterial challenge. We pretreated mice with PGN and studied the response of the mice to a subsequent challenge with live S. aureus, a bacterium frequently associated with nosocomial infections and a major pathogen in critically ill patients (14) .
MATERIALS AND METHODS
Tolerance Model. Male, 6-to 8-wk-old wild-type C57BL/6J, C3H/HeJ, and TLR2 knockout (B6.129-Tlr2 tm1kir /J) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). Mice were housed in a monitored, light-dark cycled environment and provided with standard lab chow and water ad libitum. PGN, derived from Staphylococcus aureus, was purchased from Sigma Chemical (St. Louis, MO). Mice were injected with PGN (1 mg in 0.1 mL of saline intraperitoneally) once daily for two consecutive days. Control mice received normal saline (0.1 mL) in the same regimen. All mice were injected at the same time each morning. All studies were approved by the Institutional Animal Care and Use Committee at the University of Texas Medical Branch and met National Institutes of Health guidelines for the use of experimental animals in research.
Staphylococcus-Induced Challenge. S. aureus (strain 14458, American Type Culture Collection, Rockville, MD) was inoculated into nutrient broth and allowed to replicate overnight in a shaking incubator at 37°C. The resulting bacterial culture was washed with 10 mL of sterile 0.9% saline. Viable numbers of colony-forming units (cfu) were determined by plating serial dilutions overnight on nutrient agar. Bacteria were suspended in sterile 0.9% saline at a final concentration of 1 ϫ 10 9 cfu/mL. Mice were challenged with 0.1 mL of this suspension (1 ϫ 10 8 cfu; intravenously) 2 days after the second dose of PGN.
Bacterial Clearance. The mice were killed under isoflurane 6 hrs after intravenous injection of S. aureus. Spleen and liver samples were aseptically excised, weighed, and homogenized in sterile saline using sterile tissue grinders. Serial dilutions of tissue homogenates were plated on nutrient agar and incubated overnight at 37°C. Bacterial colonyforming units were counted to assess bacterial burden.
Enzyme-Linked Immunosorbent Assay. Blood samples were collected 6 hrs after the Staphylococcus challenge and plasma cytokine concentrations were measured by enzyme-linked immunosorbent assay. Interferon (IFN)-␥, interleukin (IL)-10, and tumor necrosis factor (TNF)-␣ enzyme-linked immunosorbent assay kits (eBiosciences, San Diego, CA) were used to measure cytokine concentrations in plasma according to the manufacturer's instructions. Briefly, standards or experimental samples were added to 96-well plates coated with monoclonal antibody against the cytokine of interest and incubated for 2 hrs. After washing, horseradish peroxidase-conjugated, cytokine-specific antibody was added to each well, incubated for 2 hrs, and washed. Substrate solution (TMB, Sigma Chemical) was added and incubated for 30 mins, and the reaction was terminated by the addition of stop solution (2NH 2 SO 4 ). Cytokine concentrations were determined by measuring optical density at 450 nM using a microtiter plate reader (Dynatech Laboratories, Chantilly, VA).
Data Analysis. Results are presented as mean Ϯ SEM. Sample data comparing two groups were analyzed by unpaired Student's t-test, whereas data from multiple groups were analyzed by analysis of varaince and post hoc Tukey's test. Survival curves were analyzed by log-rank test. A value of p Ͻ 0.05 was considered statistically significant.
RESULTS
Pretreatment with PGN induced a cytokine response but suppressed the inflammatory response to subsequent bacterial challenge. Pretreatment of mice with PGN resulted in elevated plasma concentrations of TNF-␣ and IL-10, but not IFN-␥, at 6 hrs after injection (Table 1 ). In the absence of further challenge, these cytokines were not detectable 48 hrs later. However, mice challenged with S. aureus 48 hrs after pretreatment with PGN had suppressed IFN-␥ (p Ͻ 0.05) and TNF-␣ (p Ͻ 0.01) and increased IL-10 (p Ͻ 0.001) responses compared with saline pretreated control mice ( Fig. 1 ).
Pretreatment with PGN was associated with enhanced bacterial clearance and improved survival in response to a S. au- reus challenge. To test the immunologic significance of PGN pretreatment and the effect of the altered cytokine profile in response to S. aureus challenge, bacterial clearance was studied in mice that were challenged with S. aureus 48 hrs after pretreatment with PGN. Mice pretreated with PGN had three-fold lower concentrations of bacterial cfu in spleen (p Ͻ 0.01) and about 50% lower cfu in liver (p Ͻ 0.01) tissues compared with salinetreated control animals (Fig. 2) . To further determine the immunologic consequences of the effects of pretreatment with PGN, survival was observed for 7 days in mice after challenge with a highly lethal inoculum of S. aureus. Only 2 of 10 mice pretreated with PGN died during the observation period, compared with 80% mortality in control mice by day 5 (p ϭ 0.011) ( Fig. 3 ). PGN-induced tolerance and enhancement of innate immune function was independent of signaling through the TLR4 receptor. To test whether TLR4 signaling was necessary for the effects of PGN pre-treatment and to verify that the effects of PGN pretreatment were not due to LPS contamination, C3H/HeJ mice were pretreated with PGN 48 hrs before a challenge with S. aureus, and killed 6 hr later for sample collection. As was demonstrated in wild-type C57BL/6 mice, pretreatment of C3H/HeJ mice with PGN was associated with diminished induction of IFN-␥ (p Ͻ 0.01) and TNF-␣ (p Ͻ 0.001) in response to the S. aureus challenge when compared with saline-pretreated C3H/HeJ mice (Fig. 4) . The plasma IL-10 response to the Staphylococcus challenge was higher, but not statistically different in mice pretreated with PGN compared with saline-pretreated controls ( Fig. 4) . Similarly, bacterial counts in spleen tissues were lower in mice pretreated with PGN compared with saline-pretreated controls (p Ͻ 0.01 in both HeJ and OuJ), although liver bacterial counts were not significantly different ( Fig. 5 ). PGN-pretreated C3H/HeJ (p ϭ 0.0327) and C3H/HeOuJ (p ϭ 0.0128) mice also had a higher percentage of survival after S. aureus challenge compared with saline-pretreated control mice (Fig. 6 ). The effects of PGNpretreatment on plasma cytokine profile, bacterial clearance, and mortality results were similar to those seen in the C57BL6 mice described and also similar to results observed in C3H/HeOuJ mice, which do not have the point mutation and thus have intact TLR4 signaling.
PGN-induced tolerance and enhancement of innate immune function was independent of signaling through the TLR2 receptor. To test whether TLR2 signaling was necessary for the effects of PGN pretreatment, TLR2 knockout mice were pretreated with PGN 48 hrs before a challenge with S. aureus, and killed 6 hrs later for sample collection. As was demonstrated in wild-type mice, pretreatment of TLR2 knockout mice with PGN was associated with diminished plasma concentrations of IFN-␥ (p Ͻ 0.05) and TNF-␣ (p Ͻ 0.001) in response to a S. aureus challenge when compared with saline-pretreated control mice (Fig. 7) . The plasma IL-10 response to a Staphylococcus challenge was higher in TLR2 knockout mice pretreated with PGN compared with saline-pretreated controls (p Ͻ 0.05) ( Fig. 7) . Similarly, bacterial counts in spleens were significantly lower in TLR2 knockout mice pretreated with PGN compared with mice pretreated with saline (p Ͻ 0.001) ( Fig. 8) . PGN-pretreated TLR2Ϫ/Ϫ mice also had a higher percentage of survival after S. aureus challenge compared with saline-pretreated control mice (p ϭ 0.0128) ( Fig.  9 ), and these results were similar to those observed in the background strain C57BL6 mice (Fig. 3 ).
DISCUSSION
These studies demonstrate that, similar to LPS from Gram-negative bacteria, PGN from the cell wall of Gram-positive bacteria can reduce inflammation and enhance innate immune function in mice in response to a subsequent bacterial challenge. In the present study, tolerance was manifested by a diminished proinflammatory cytokine (TNF-␣) response; diminished Th1 cytokine response (IFN-␥); and an increased Th2 cytokine response (IL-10). Despite the predominant Th2 response to the S. aureus challenge, tolerant animals demonstrated enhanced bacterial clearance and greatly attenuated mortality after the S. aureus challenge. Neither TLR2 nor TLR4 signaling were necessary for these effects and the results in LPS-resistant C3H/HeJ mice suggested that the tolerance induction was not a result of LPS contamination of the PGN. LPS tolerance was first described in 1947 by Beeson who noted that consecu-tive administrations of fractionated bacterial suspensions to rabbits were associated with progressively diminished physiologic responses (15) . Since these observations, LPS has been reported to induce tolerance to a variety of other stimuli and injuries, including tolerance to CpG DNA (16), TNF-␣ and IL-1␤ (17), ethanol intoxication (18) and an attenuation of inflammation and injury after a variety of ischemic insults (2-7). Similarly, tolerance to LPS has been described to occur after a variety of other pretreatments, including cytokines (17, 19) , heat shock proteins (20, 21) , and other bacterial peptides including lipoproteins and lipoteichoic acid (LTA) (22) (23) (24) . In the last few decades, a number of studies of tolerance have been conducted with isolated cells. In vivo study of tolerance induction offers an advantage over in vitro or ex vivo studies in that a functional immune end point (bacterial clearance) can be studied directly. Further, different cell types and origins have had conflicting results in cell culture under the same experimental conditions (25) . Tolerance to components of Grampositive bacterial cell walls has not been studied as extensively as tolerance induced by LPS. In cell culture, exposure of macrophages to either LTA or PGN results in suppression of cytokine release after restimulation with the same molecule (24, 26) . In the case of LTA, tolerance induction was dependent upon TLR2 (24) . In animal models, pretreatment with LTA reduced cardiac injury induced by ischemia/reperfusion similar to the protection provided by pretreatment with LPS (27) . There are few studies of Gram-positive tolerance induction and subsequent effects on innate immune function. Recognition of microbial organisms is the first step in host defense. The role of the innate immune system is to recognize a vast number of different pathogens and to distinguish them from self. LTA, PGN, and other bacterial molecules such as LPS of Gram-negative bacteria are highly conserved across broad classes of bacteria and, as such, provide the innate immune system with an efficient method for detection of a diverse multitude of microbial organisms. A consequence of the interaction of these pathogen-associated molecular patterns with TLRs on macrophages, monocytes, and neutrophils is up-regulation of inflammatory gene expression and subsequent release of inflammatory cytokines and chemokines. Both TLR2 and the alternative innate immune receptor NOD2 have been described as required for a full response to S. aureus (30, 31) , although our study seems to demonstrate that neither TLR2 knockout nor TLR4 deficient (HeJ) control mice cleared the bacterial challenge as efficiently as the wild-type control mice. Further, both TLR2 knockout and TLR4 deficient mice had a more pronounced TNF-␣ and IFN-␥ cytokine response when compared with their respec-tive wild-type groups suggesting that TLR2 and TLR4 signaling may play a role in the regulation of those cytokines.
Although it is not surprising that a defect in TLR2 signaling would be associated with increased susceptibility to a Gram-positive bacterial infection (31), it is not clear why the C3H/HeJ mice had worse bacterial clearance and mortality compared with the OuJ control mice groups. The point mutation involving the TLR4 receptor renders mice more susceptible to Gram-negative bacterial infections (32) but previous investigations in C3H/HeJ mice have not reported an increased susceptibility to S. aureus compared with C3H strains with intact TLR4 signaling. During the course of these studies, we attempted to minimize variability by purchasing both strains at the same time from the same vendor; housing under the same conditions; and infecting and sampling the mice at the same time. It is possible that additional genetic drift has occurred between these two C3H strains since their separation in the 1960s that either renders the HeJ mice more susceptible or the OuJ mice less susceptible to Staphylococcus. Nevertheless, PGN administration effectively enhanced innate immune function in both TLR2Ϫ/Ϫ and HeJ mice compared with saline-treated TLR2Ϫ/Ϫ or HeJ mice, suggesting that the enhancement of immune function occurred through mechanisms other than TLR2 and TLR4 signaling. This may have involved activity downstream of NOD2 receptor activation. PGN, consisting of glycan strands crosslinked by peptides, is the major component of the cell wall of Gram-positive bacteria. Detection and activation of immune cells in response to PGN is not only Figure 9 . TLR2 knockout mice were pretreated with peptidoglycan (PGN) before challenge with live Staphylococcus aureus. The mice were observed for mortality for 7 days after the challenge. Mice that were pretreated had significantly better survival after the S. aureus challenge than control mice. *p Ͻ 0.05, n ϭ 5 per group.
through TLR2 but also through alternate pattern recognition receptors including NOD1 and NOD2, CD14, and a family of PGN recognition proteins (33) . Other investigators have demonstrated that additional receptors, such as C5aR, contribute significantly to the immune response of TLR2 knockout mice to S. aureus (34) and it remains possible that the mechanism of PGN-induced tolerance worked through these as well.
Other components of Gram-positive bacteria include LTA which is a polymer anchored in the outer cytoplasmic membrane by a lipid moiety and, as such, is the Gram-positive bacterial equivalent to LPS from Gram-negative bacteria. LPSbinding protein and CD14 facilitate recognition of LTA, although cell stimulation occurs through TLR2 rather than TLR4 (35, 36) . We have tested LTA in experiments similar to those in this report and found that tolerance induction did occur although not as strongly compared with that induced by PGN (unpublished observations).
It was interesting to note that although lack of TLR2 or TLR4 signaling seemed to be associated with diminished ability to clear bacteria in untreated mice, neither was necessary for the induction of tolerance and enhancement of bacterial clearance. How tolerance induction exerts a positive effect on bacterial clearance is not entirely clear. The number of phagocytic cells is increased after tolerance induction, and surface expression of complement receptor 3 and Fc␥III/IIR have been shown to be increased on cells from tolerant animals (23) . Both of those molecules have roles in phagocytosis, so tolerance enhancement of bacterial clearance may be due to increased numbers and activity of phagocytic cells. Recent work confirms that phagocytosis is significantly improved after induction of tolerance by LPS (37) .
The clinical relevance of tolerance induction is unclear. Septic patients often have anti-inflammatory cytokine profiles, and ex vivo stimulation of leukocytes from septic patients has demonstrated suppression of the inflammatory response. Sepsis due to Gram-positive infections has been associated with a lesser degree of macrophage hyporesponsiveness to inflammatory stimuli than that seen in patients with Gram-negative sepsis (38) . Our previous work combined with the present study demonstrates that pretreatment of mice with either Gramnegative or Gram-positive molecules re-sults in a diminished proinflammatory response to a subsequent bacterial challenge. At the same time, however, we observed enhanced innate immune function as manifested by accelerated bacterial clearance and decreased mortality and thus induced tolerance differs significantly from clinical cases of sepsis. Whether this occurs as a natural phenomenon, i.e., whether there are groups of patients who suffer minor injuries or infections that are followed by a period of enhanced bacterial resistance, is unknown. Regardless, from a clinical standpoint understanding the mechanism of LPS tolerance is of obvious interest because reduction of the proinflammatory response may have important benefits, especially if it can be achieved while maintaining or even enhancing the innate immune clearance of pathogenic organisms.
CONCLUSIONS
Exposure to PGN derived from the cell wall of Gram-positive bacteria diminished the proinflammatory response but enhanced the innate immune response of mice to subsequent live bacterial challenges.
